Peer-influenced content. Sources you trust. No registration required. This is HCN.
Ophthalmology Management
Reproxalap is an investigational drug candidate for the treatment of dry eye disease.
Ophthalmology March 24th 2026
Consultant360
“Today’s approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment.” – Iilun Murphy, MD, Director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research
Allergy & Immunology March 12th 2026
MedCentral
The new chemical entity is an atypical antipsychotic and the active metabolite of iloperidone (Fanapt). Its ability to cross the blood-brain barrier likely contributes to iloperidone’s clinical effects.
Psychiatry March 4th 2026
Conexiant
“We are delivering on our promise to make sure women have accurate, scientifically grounded information about the potentially life-changing benefits of HRT.” — FDA Commissioner Marty Makary, MD, MPH
Obstetrics & Gynecology February 24th 2026
The Aptima HPV assay uses messenger RNA detection to identify infections most likely to lead to cervical cancer.
Obstetrics & Gynecology February 11th 2026
Medical Professionals Reference (MPR)
64% of those who self-administered Cardamyst converted to sinus rhythm within 30 minutes compared with 31% who received placebo.
Cardiology February 10th 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS